Physalin B reduces Aβ secretion through down-regulation of BACE1 expression by activating FoxO1 and inhibiting STAT3 phosphorylation

• Published in: Chinese journal of natural medicines 2021-10, Vol.19 (10), p.732-740
• Main Authors: ZHANG, Wei, BAI, Shan-Shan, ZHANG, Qi, SHI, Ru-Ling, WANG, He-Cheng, LIU, You-Cai, NI, Tian-Jun, WU, Ying, YAO, Zhao-Yang, SUN, Yi, WANG, Ming-Yong
• Format: Article
• Language: English
• Subjects: Alzheimer's disease; BACE1; FoxO1; Physalin B; β-amyloid
• ISSN: 1875-5364; 1875-5364
• DOI: 10.1016/S1875-5364(21)60090-0

Physalin B (PB), one of the major active steroidal constituents of Solanaceae Physalis plants, has a wide variety of biological activities. We found that PB significantly down-regulated β-amyloid (Aβ) secretion in N2a/APPsw cells. However, the underlying mechanisms are not well understood. In the current study, we investigated the changes in key enzymes involved in β-amyloid precursor protein (APP) metabolism and other APP metabolites by treating N2a/APPsw cells with PB at different concentrations. The results indicated that PB reduced Aβ secretion, which was caused by down-regulation of β-secretase (BACE1) expression, as indicated at both the protein and mRNA levels. Further research revealed that PB regulated BACE1 expression by inducing the activation of forkhead box O1 (FoxO1) and inhibiting the phosphorylation of signal transducer and activator of transcription 3 (STAT3). In addition, the effect of PB on BACE1 expression and Aβ secretion was reversed by treatment with FoxO1 siRNA and STAT3 antagonist S3I-201. In conclusion, these data demonstrated that PB can effectively down-regulate the expression of BACE1 to reduce Aβsecretion by activating the expression of FoxO1 and inhibiting the phosphorylation of STAT3.